Newsroom

ManaMed^® Announces the Launch of Three Innovative Products: ManoFX, ManaCold Platinum 2.0, and ManaGo 71

Bold, Modern, and Future-focused: ManaMed Redefines its Presence in the Medical Device Industry

ManaMed LLC, a global leader in orthopedic mobility and post-operative rehabilitation equipment, announced it has completed a major rebranding effort. The revitalized brand identity reaffirms ManaMed's unwavering dedication to growth and pioneering innovation in the medical device sector.

MANAMED Announces Leadership Appointments

ManaMed LLC, a global leader in orthopedic mobility and post-operative rehabilitation equipment, announced several new leadership appointments. The new company structure highlights the Company's commitment to innovation and the customers they serve in the medical device market.

MANAMED Receives Expanded 510(k) Clearance for ManaFlexx 2

The US Food and Drug Administration (FDA) has granted over-the- counter marketing clearance for the ManaFlexx 2®, an Electrical Stimulation (EMS) device, from MANAMED®, LLC. ManaFlexx 2 is a compact medical device that delivers electrical pulses to the user’s skin through the company’s patented wireless technology for two distinct uses. The expanded indication applies to both ManaFlexx 2 device’s indications: Neuromuscular Electrical Stimulation (NMES) and Transcutaneous Electrical Nerve Stimulation (TENS).

Cutting-Edge PlasmaFlow Device Receives UnitedHealthcare Coverage

ManaMed strives to be at the forefront of medical innovation, which is why it is excited to announce that its DVT prevention device, PlasmaFlow, has just received UnitedHealthcare coverage.

Revolutionary Wearable Ultrasound Device Gains FDA Approval

ManaMed (ManaMed.com) is proud to announce the U.S. Food and Drug Administration (FDA) approval for the ManaSport™ ultrasound therapy Class II device. The ManaSport™ device, is a new ultrasound therapy device that provides pain relief and treatment for soft tissue injuries and is popular among athletes and sports professionals.

ManaMed Inc. Named Official Partner of the UFC Performance Institute

LAS VEGAS (February 23, 2022) – ManaMed Inc., a leading provider of orthopedic devices that range from bracing, soft goods, electrical stimulation and vascular therapy devices, and the UFC Performance Institute (UFC PI), the world’s leading high-performance service provider for mixed martial arts (MMA) athletes, today announced a multi-year partnership in which ManaMed products will be made available to UFC athletes who utilize UFC PI services.

ManaMed Ranked No. 992 on the 2021 Inc. 5000 With 485% Three-Year Revenue Growth

ManaMed™ Inc., a leading provider of orthopedic devices, is proud to announce its ranking on Inc. 5000, the most prestigious ranking of the nation's fastest-growing private companies.

ManaMed Inc. Introduces PlasmaFlow, The World's First FDA-Approved Digital and Tubeless Deep Vein Thrombosis Prevention Device

The company's historical first FDA-approved portable and tubeless DVT prevention device is now available to medical practitioners and patients throughout the United States.